Evidence map›Paper›PMID 36970058›Full record

ArticleCancer research communications2022

Multiregional Sequencing Analysis Reveals Extensive Genetic Heterogeneity in Gastric Tumors from Latinos.

Ted W Toal, Ana P Estrada-Florez, Guadalupe M Polanco-Echeverry, Ruta M Sahasrabudhe, Paul C Lott, John J Suarez-Olaya, Alix A Guevara-Tique, Sienna Rocha, Alexa Morales-Arana, Fabian Castro-Valencia and 10 more

Open access · goldFull text read
In one paragraph

Article in Cancer research communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. The Landscape of Genomic and Socioeconomic Variables in Patients with Colorectal Cancer Based on Genetic Ancestry.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Genomic ancestry and cancer among Latin Americans.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 3 countries.

Ted W ToalGenome Center, University of California, Davis, California.ORCID 0000-0002-0967-4998
Ana P Estrada-FlorezGenome Center, University of California, Davis, California.ORCID 0000-0001-5480-693X
Guadalupe M Polanco-EcheverryGenome Center, University of California, Davis, California.
Ruta M SahasrabudheGenome Center, University of California, Davis, California.
Paul C LottGenome Center, University of California, Davis, California.ORCID 0000-0002-1611-442X
John J Suarez-OlayaGrupo de Citogenética, Filogenia y Evolución de las Poblaciones, Universidad del Tolima, Ibagué, Colombia.
Alix A Guevara-TiqueGrupo de Citogenética, Filogenia y Evolución de las Poblaciones, Universidad del Tolima, Ibagué, Colombia.ORCID 0000-0003-0856-5455
Sienna RochaGenome Center, University of California, Davis, California.
Alexa Morales-AranaGenome Center, University of California, Davis, California.ORCID 0000-0001-8409-6959
Fabian Castro-ValenciaGrupo de Citogenética, Filogenia y Evolución de las Poblaciones, Universidad del Tolima, Ibagué, Colombia.
Shiro UrayamaUC Davis Comprehensive Cancer Center, Sacramento, California.ORCID 0000-0001-6574-3161
Amanda KiraneUC Davis Comprehensive Cancer Center, Sacramento, California.
Dongguang WeiDepartment of Pathology and Laboratory Medicine, University of California, Davis, California.ORCID 0000-0003-0339-6381
Nora Rios-SarabiaUnidad de Investigación en Enfermedades Infecciosas y Parasitarias, Unidad Médica de Alta Especialidad en Pediatría, Instituto Mexicano del Seguro Social, México City, México.ORCID 0000-0002-1341-0581
Rafael MedranoDepartamento de Sarcomas y Tubo Digestivo Alto, Unidad Medica de Alta Especialidad en Oncología Instituto Mexicano del Seguro Social (IMSS), México City, México.ORCID 0000-0001-6484-3996
Alejandra MantillaDepartamento de Patología, Unidad Medica de Alta Especialidad en Oncología, Instituto Mexicano del Seguro Social (IMSS), México City, México.ORCID 0000-0002-5085-6216
Magdalena Echeverry de PolancoGrupo de Citogenética, Filogenia y Evolución de las Poblaciones, Universidad del Tolima, Ibagué, Colombia.
Javier TorresUnidad de Investigación en Enfermedades Infecciosas y Parasitarias, Unidad Médica de Alta Especialidad en Pediatría, Instituto Mexicano del Seguro Social, México City, México.ORCID 0000-0003-3945-4221
Mabel E Bohorquez-LozanoGrupo de Citogenética, Filogenia y Evolución de las Poblaciones, Universidad del Tolima, Ibagué, Colombia.
Luis G Carvajal-CarmonaGenome Center, University of California, Davis, California.ORCID 0000-0001-7129-2918
University of California, Davis · USUniversity of Tolima · COMexican Social Security Institute · MXComprehensive Blood & Cancer Center · USUniversity of California System · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health DisparitiesU54CA233306 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARVAJAL CARMONA, LUIS GUILLERMO, CHEN, MOON SHAO-CHUANG · 2018 to 2022
$6.8M
Genetic studies of homologous recombination deficiency in hispanic gastric cancerR01CA223978 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARVAJAL CARMONA, LUIS GUILLERMO · 2018 to 2022
$3.0M
Dissecting gastric cancer clonality with genomic analyses and patient xenograftsR21CA199631 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARVAJAL CARMONA, LUIS GUILLERMO · 2016 to 2017
$376k
NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA223978NCI NIH HHS R21 CA199631NCI NIH HHS U54 CA233306
6 · The paper itself

Abstract

Gastric cancer is a leading cause of cancer mortality and health disparities in Latinos. We evaluated gastric intratumoral heterogeneity using multiregional sequencing of >700 cancer genes in 115 tumor biopsies from 32 patients, 29 who were Latinos. Analyses focused on comparisons with The Cancer Genome Atlas (TCGA) and on mutation clonality, druggability, and signatures. We found that only approximately 30% of all mutations were clonal and that only 61% of the known TCGA gastric cancer drivers harbored clonal mutations. Multiple clonal mutations were found in new candidate gastric cancer drivers such as Significance: Our study contributes to advancing our knowledge of gastric carcinogenesis, diagnostics, and cancer health disparities.

Indexed as

Genetic HeterogeneityHispanic or LatinoStomach NeoplasmsAsianCarcinogenesisEye ProteinsHumansMutationPrognosisWhiteEye ProteinsEYS protein, human

Identifiers

PMID36970058
PMCPMC10035402
OpenAlexW4308440597

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read39
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.